Clinical Trial Update: Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE) [Phase 3]

View source ↗

Summary

This document reports a safety review from a Phase 3 trial (RE-SURGE) evaluating rilonacept to prevent gout exacerbations. Results for the trial were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Arcalyst (rilonacept)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2017-04-28